I am an Associate Member in the Department of Medical Physics. I work to combine
techniques from machine learning and estimation theory with computer vision methods to
solve challenging problems involving multi-modality image analysis including segmentation
of tumors and normal tissues, longitudinal tracking of tumor treatment response and
prediction of subsequent development of toxicities to cancer treatments from computed
tomography (CT), cone beam CT used in radiotherapy treatments, as well as magnetic
resonance (MR) images. I am the director of AI for Image Guided Therapies Lab where we
develop and translate new artificial intelligence (AI) and deep learning methods for clinical
use. Four different AI models developed by my group are used for radiotherapy treatment
planning for prostate, breast, lung, and head and neck cancers with additional disease sites
planned for release into clinical use this year.
After receiving a PhD in computer science in 2006 from the University of Minnesota, Twin
Cities, I developed algorithms for human robot interaction using machine learning and
computer vision as a postdoctoral fellow in the Computer Science Department at Carnegie
Mellon. Subsequently, I worked as a computer vision scientist for General Electric Research,
developing image analysis algorithms for interactive segmentation with active learning for
robust tumor segmentation and techniques for multiple modality segmentation of hard-to-
detect metastatic breast, kidney, and skin cancers.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Harini Veeraraghavan discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures